News Shilpa Medicare Limited NSE India S.E.

Equities

SHILPAMED

INE790G01031

Market Closed - NSE India S.E. Other stock markets 07:43:53 2024-05-06 am EDT			5-day change	1st Jan Change
521.8 ^INR	-2.84%		-2.74%	+57.98%

Apr. 18	Shilpa Medicare Partner Amneal Pharma Launches Ready-to-Use Pemetrexed in US	MT
Apr. 17	Shilpa Medicare Gets GMP Certification from Austrian Agency for Telangana, India Unit	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Shilpa Medicare Partner Amneal Pharma Launches Ready-to-Use Pemetrexed in US	Apr. 18	MT
Shilpa Medicare Gets GMP Certification from Austrian Agency for Telangana, India Unit	Apr. 17	MT
Shilpa Medicare Gets Board Nod to Launch QIP	Apr. 09	MT
Shilpa Medicare's Life Science Arm Names CEO	Mar. 28	MT
Shilpa Medicare's New Unit in Hyderabad, India Gets Zero Observations from US FDA	Mar. 01	MT
Shilpa Medicare Gets Approval to Market Smoking Cessation Drug in Europe	Feb. 26	MT
Transcript : Shilpa Medicare Limited, Q3 2024 Earnings Call, Feb 12, 2024	Feb. 12
Shilpa Medicare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 08	CI
Shilpa Medicare Gets Germany's Marketing Approval for Rare Muscles Diseases Drug	Jan. 19	MT
Shilpa Medicare Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 10	CI
Shilpa Medicare Acquires US-Based Pilnova Pharma	Nov. 02	MT
Shilpa Medicare Limited Launches Naturally Derived Option for the Treatment of Oral Mucositis in India Under the Brand Name Oraal	23-10-11	CI
Shilpa Medicare Unit's API Manufacturing Plant Gets Clearance from Japanese Drug Regulator's Inspection	23-09-04	MT
Shilpa Medicare Gets UK Drug Regulator's Nod to Market Drug for Meniere's Syndrome Symptoms	23-09-04	MT
Shilpa Medicare Limited Receives Marketing Authorization from MHRA, UK, for Betahistine Dihydrochloride Orodispersible Films, 24 mg	23-09-01	CI
Shilpa Medicare's Manufacturing Facility in Telangana Gets Clearance from Brazilian Regulator	23-08-25	MT
Transcript : Shilpa Medicare Limited, Q1 2024 Earnings Call, Aug 11, 2023	23-08-11
Shilpa Medicare Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-10	CI
Shilpa Medicare Limited Announces Issuance of Redeemable Non-Convertible Debentures for its 2 Wholly Owned Subsidiaries	23-08-08	CI
Shilpa Medicare Gets Regulatory Nod for Pemetrexed Injections	23-07-31	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Shilpa Medicare Limited NSE India S.E.

Equities

SHILPAMED

INE790G01031

Summary

Filters